NewKerala.com

Budget 2026-27: A Futuristic Blueprint for Viksit Bharat 2047, Says Govt

Union Minister Dr. Jitendra Singh hailed the Union Budget 2026-27 as a "very futuristic" blueprint charting a roadmap for the next 25 years, aligning with the 2047 vision of 'Viksit Bharat'. He highlighted the significant Rs 10,000 crore allocation for the Biopharma Shakti mission to develop India as a global hub for biologics and biosimilars. The budget also includes plans to strengthen clinical trial infrastructure and the Central Drugs Standard Control Organisation. The presentation was praised by other leaders as progressive and development-oriented, with PM Modi calling it a strong foundation for the nation's future.

Key Points: Budget 2026-27 Hailed as Futuristic Roadmap for Viksit Bharat

  • Rs 10,000 crore Biopharma Shakti mission
  • Roadmap for Viksit Bharat 2047
  • Focus on technology and biologics
  • Strengthening drug regulatory framework
2 min read

"Futuristic": Union Minister Jitendra Singh hails Budget 2026-27

Union Minister Jitendra Singh praises the 2026-27 Budget as a futuristic plan for the next 25 years, focusing on tech and a Rs 10,000 crore Biopharma mission.

"It is a very futuristic budget and a budget for the next quarter of a century - Jitendra Singh"

New Delhi, February 1

Union Minister Dr Jitendra Singh on Sunday described the Union Budget 2026-27 as a "very futuristic" blueprint, charting a roadmap for the next 25 years, including India's 2047 vision of 'Viksit Bharat'.

"It is a very futuristic budget and a budget for the next quarter of a century... it lays out the roadmap for the next 25 years, which also includes the year 2047 of 'Viksit Bharat'... I'm glad that most of the new announcements from the finance minister today are related to technology. The Bio Pharma announcement is the most important: Rs 10,000 crore for the Bio Pharma Shakti mission and the Bio Pharma Shakti scheme," Jitendra Singh said.

According to the Ministry of Finance, to develop India as a global Biopharma manufacturing hub, the Biopharma SHAKTI, with an outlay of Rs 10,000 crores to build the ecosystem for domestic production of biologics and biosimilars, will be set up over the next 5 years.

It will also create a network of over 1,000 accredited clinical trial sites. The Central Drugs Standard Control Organisation will be strengthened to meet global standards and approval timeframes through a dedicated scientific review cadre and specialists. The Strategy will include a Biopharma-focused network with 3 new National Institutes of Pharmaceutical Education and Research (NIPER) institutes and the upgrading of 7 existing ones, ministry said.

BJP Karnataka leader Basavaraj Bommai described the budget as "progressive and development-oriented."

"It is a progressive and development-oriented budget. Amid global geopolitical challenges, Finance Minister Nirmala Sitharaman has presented a very dynamic budget that will lead the country on the right path," Bommai told ANI.

Finance Minister Nirmala Sitharaman today rose in the Lok Sabha to present the Union Budget. She presented her ninth consecutive Budget.

Earlier today, Prime Minister Narendra Modi hailed the Union Budget 2026-27 as a "strong foundation" for India's journey towards Viksit Bharat 2047, saying it would provide fresh energy and speed to the 'reform express' on which the country is riding.

PM Modi emphasised that citizens are the greatest asset and that the government has made unprecedented investments to enhance their capabilities.

- ANI

Share this article:

Reader Comments

P
Priya S
Sounds promising, but I hope the benefits reach the common man. Strengthening 1000+ clinical trial sites is great for research, but what about making existing hospitals and primary health centres stronger? The vision for 2047 is exciting, but we need solid steps for today's healthcare challenges too.
R
Rohit P
As someone working in the pharma sector in Hyderabad, this is massive news! The ₹10,000 crore for Biopharma SHAKTI and new NIPER institutes will be a game-changer for R&D. Finally, we can compete with global giants on innovation, not just generic manufacturing. Future is here! 🚀
S
Sarah B
Investing in the future is crucial, but I'm curious about the immediate economic impact. With global challenges mentioned, how does this budget address inflation and cost of living for middle-class families right now? The 25-year vision is important, but so is the present.
K
Karthik V
"Reform express" is the right term! After seeing the infrastructure push in previous budgets, this focus on cutting-edge technology and biopharma shows a clear, long-term strategy. If executed well, this can put Indian science on the world map. Jai Vigyan! 🙏
M
Michael C
The emphasis on meeting global standards for drug approval is critical. Faster, world-class regulatory processes will attract more international investment and partnerships. This is a smart move to integrate India deeper into the global healthcare supply chain.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50